ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19

NCT04604184 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

133

Enrollment

INDUSTRY

Sponsor class

Stopped Company decision

Conditions

COVID-19

Interventions

DRUG: BI 764198
DRUG: Placebo

Sponsor

Boehringer Ingelheim